In T-ALL, Cluster 1 had a good prognosis despite CDKN2A LOH; Cluster 2 showed aggressive features with biallelic deletions; Cluster 3 lacked LOH of the CDKN2A gene and was characterized by a genetically stable profile. The gene discussed is CDKN2A; the disease is acute lymphoblastic leukemia.